165 results
Page 4 of 9
8-K
EX-99.1
lzx6v 14w4w
17 Oct 19
Cellectar Announces Poster at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston
4:09pm
8-K
EX-99.1
vimthfs6c7n
8 Oct 19
Cellectar Announces Presentation at the Cancer Research UK-AACR Joint Conference on Engineering and Physical Sciences in Oncology
4:01pm
8-K
EX-99.1
dgds58 f08
16 Sep 19
Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma
4:02pm
8-K
EX-99.1
4giszh6cepm0ht63
10 Sep 19
Cellectar Announces Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
4:42pm
8-K
EX-99.1
xaqzk jwbhvayx2aesvc
4 Sep 19
Cellectar Announces Late-Breaker Poster Presentation at the 17th International Myeloma Workshop
4:08pm
D
pc579
31 May 19
$14.65M in equity / options, sold $5.05M, 11 investors
5:17pm
8-K
EX-10.3
f6ipa24os87o959voy
20 May 19
Cellectar Biosciences Announces Closing of $10.0 Million Financing
5:30pm
8-K
EX-1.1
3wp5fjugq wtc
20 May 19
Cellectar Biosciences Announces Closing of $10.0 Million Financing
5:30pm
8-K
EX-10.2
zfuko
20 May 19
Cellectar Biosciences Announces Closing of $10.0 Million Financing
5:30pm
8-K
EX-10.1
2kn8j8z93wa
20 May 19
Cellectar Biosciences Announces Closing of $10.0 Million Financing
5:30pm
8-K
EX-10.1
dphdmh
19 Apr 19
Departure of Directors or Certain Officers
8:00am